Document Detail

Nonpseudomonal ecthyma gangrenosum associated with methicillin-resistant staphylococcus aureus infection: a case report and review of the literature.
MedLine Citation:
PMID:  22988648     Owner:  NLM     Status:  MEDLINE    
Ecthyma gangrenosum (EG) is a skin infection that is classically associated with Pseudomonas aeruginosa septicemia in immunocompromised patients. Other bacterial, viral, and fungal pathogens also have been implicated in EG. Both bacteremic and nonbacteremic forms of EG have been described. We describe a case of EG associated with methicillin-resistant Staphylococcus aureus (MRSA) in a 35-year-old woman with acute lymphoblastic leukemia (ALL) and review the literature.
Aileen Y Chang; Casey A Carlos; Mindy Schuster; Xiaowei Xu; Misha Rosenbach
Related Documents :
24807578 - Book reviews.
16133408 - Escherichia coli endocarditis: seven new cases in adults and review of the literature.
6505898 - Staphylococcus aureus tricuspid valve endocarditis in young women after gynaecological ...
2245038 - Streptococcal endocarditis temporally related to transesophageal echocardiography.
8943448 - Toxic methemoglobinemia after topical anesthesia for transesophageal echocardiography.
21906158 - Coexistence of two atypical variants of pityriasis rosea: a case report and review of l...
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Cutis     Volume:  90     ISSN:  0011-4162     ISO Abbreviation:  Cutis     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-09-19     Completed Date:  2012-12-13     Revised Date:  2013-09-12    
Medline Journal Info:
Nlm Unique ID:  0006440     Medline TA:  Cutis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  67-9     Citation Subset:  IM    
Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Bacterial Agents / therapeutic use
Ecthyma / drug therapy,  microbiology*
Methicillin-Resistant Staphylococcus aureus*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
Staphylococcal Infections / complications*,  drug therapy,  microbiology
Vancomycin / therapeutic use
Reg. No./Substance:
0/Anti-Bacterial Agents; 1404-90-6/Vancomycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Full-scale in-line hydrolysis and simulation for potential energy and resource savings in activated ...
Next Document:  Whey protein precipitating moderate to severe acne flares in 5 teenaged athletes.